This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Endologix To Participate In Three Upcoming Investor Conferences

Stocks in this article: ELGX

IRVINE, Calif., May 8, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, and Shelley Thunen, Chief Financial Officer, are scheduled to participate in three upcoming investor conferences in May and June. The first conference is the Bank of America Merrill Lynch 2013 Healthcare Conference in Las Vegas. The Bank of America Merrill Lynch conference includes a formal presentation.

Event: Bank of America Merrill Lynch 2013 Healthcare Conference
Date: Tuesday, May 14, 2013
Time: 4:40 p.m. ET / 1:40 p.m. PT
Endologix Participants: John McDermott (President & CEO) and Shelley Thunen (CFO)

The second conference is the Deutsche Bank 38th Annual Healthcare Conference in Boston. The Deutsche Bank conference will utilize a fireside chat format for the presentation.

Event: Deutsche Bank 38th Annual Healthcare Conference
Date: Thursday, May 30, 2013
Time: 3:30 p.m. ET / 12:30 p.m. PT
Endologix Participant: Shelley Thunen (CFO)

The third conference is the Jefferies 2013 Global Healthcare Conference in New York. The Jefferies conference includes a formal presentation.

Event: Jefferies 2013 Global Healthcare Conference
Date: Monday, June 3, 2013
Time: 8:00 a.m. ET / 5:00 a.m. PT
Endologix Participant: Shelley Thunen (CFO)

An audio webcast of the Company's presentations at the Bank of America Merrill Lynch, Deutsche Bank and Jefferies conferences will be available by visiting the investor relations section of Endologix's website at www.endologix.com . A replay of the presentations will be available for 30 days.       

About Endologix, Inc.

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. Endologix focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's website at www.endologix.com .

CONTACT: COMPANY CONTACT:
         Endologix, Inc.
         John McDermott, CEO
         Shelley Thunen, CFO
         (949) 595-7200
         www.endologix.com
         
         INVESTOR CONTACTS:
         The Ruth Group
         Nick Laudico (646) 536-7030
         Zack Kubow (646) 536-7020

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,379.98 -298.72 -1.69%
S&P 500 2,032.89 -24.20 -1.18%
NASDAQ 4,698.7220 -73.0410 -1.53%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs